Trial intelligence / Profile preview

Intranasal dexmedetomidine dose-ranging study for ultrasound-guided brachial plexus block

ChiCTR1900023484Phase 4Recruiting

Sponsor
Wang Zhiping
Start
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in Perioperative anxiety and procedural pain (4 arms), sponsored by Wang Zhiping. Primary endpoints: Ramsay score, APAIS score and 2 more. Started Jun 2019; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

Perioperative anxietyprocedural pain

Beyond the preview

Go deeper on ChiCTR1900023484.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900023484.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call